StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences r&d expenses

Research and development expenses are spending on new products and technology.

Precision BioSciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $53.32M, down 3.7% year over year. For fiscal 2025 it was $54.17M, down 9.0% from the year before. The highest annual figure on record is $115.24M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$54.17M-9.0%
FY2024Dec 31, 2024$59.56M+11.6%
FY2023Dec 31, 2023$53.38M+15.7%
FY2022Dec 31, 2022$46.12M-60.0%
FY2021Dec 31, 2021$115.24M+17.5%
FY2020Dec 31, 2020$98.06M+19.0%
FY2019Dec 31, 2019$82.42M+82.7%
FY2018Dec 31, 2018$45.12M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.39M-2.9%
Q1 FY2026Mar 31, 2026$13.11M-3.5%
Q4 FY2025Dec 31, 2025$14.46M-9.1%
Q3 FY2025Sep 30, 2025$13.35M+2.0%
Q2 FY2025Jun 30, 2025$12.77M-25.9%
Q1 FY2025Mar 31, 2025$13.59M+1.8%
Q4 FY2024Dec 31, 2024$15.91M+18.8%
Q3 FY2024Sep 30, 2024$13.08M-17.5%
Q2 FY2024Jun 30, 2024$17.23M+31.6%
Q1 FY2024Mar 31, 2024$13.34M+20.8%
Q4 FY2023Dec 31, 2023$13.39M+5.6%
Q3 FY2023Sep 30, 2023$15.85M+34.8%
Q2 FY2023Jun 30, 2023$13.09M-42.9%
Q1 FY2023Mar 31, 2023$11.05M-44.7%
Q4 FY2022Dec 31, 2022$12.68M-52.1%
Q3 FY2022Sep 30, 2022$11.76M-54.7%
Q2 FY2022Jun 30, 2022$22.94M-38.4%
Q1 FY2022Mar 31, 2022$19.97M-22.0%
Q4 FY2021Dec 31, 2021$26.47M+14.5%
Q3 FY2021Sep 30, 2021$25.94M+4.3%
Q2 FY2021Jun 30, 2021$37.24M+47.9%
Q1 FY2021Mar 31, 2021$25.59M+2.9%
Q4 FY2020Dec 31, 2020$23.13M+16.2%
Q3 FY2020Sep 30, 2020$24.87M+25.7%
Q2 FY2020Jun 30, 2020$25.18M+10.6%
Q1 FY2020Mar 31, 2020$24.88M+24.6%
Q4 FY2019Dec 31, 2019$19.90M+21.4%
Q3 FY2019Sep 30, 2019$19.79M+103.3%
Q2 FY2019Jun 30, 2019$22.76M+109.4%
Q1 FY2019Mar 31, 2019$19.96M+145.9%
Q4 FY2018Dec 31, 2018$16.40M–
Q3 FY2018Sep 30, 2018$9.74M–
Q2 FY2018Jun 30, 2018$10.87M–
Q1 FY2018Mar 31, 2018$8.12M–

More Precision BioSciences figures

See a number that looks wrong?